Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the rank-math domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/maiwald-test.dev5.yoyaba.tech/httpdocs/wp-includes/functions.php on line 6114
Reviewed: Court Revises Own Order At Expense Of Hogan Lovells Client (Juve) – Maiwald

Reviewed: Court revises own order at expense of Hogan Lovells client (Juve)

22 Oct 2018

Numerous generics manufacturers are now allowed to sell their imitator preparations of the cholesterol-lowering drug Inegy in Germany. The Düsseldorf Regional Court overturned a preliminary injunction (Case No. 4b O37/18 to 4b O43/18) by which it had banned the sale of generics in the spring. The American originator Merck Sharp Dome (MSD) had sued the manufacturers for injunction. The court initially granted the application, but has now lifted the ban.

Representatives 1 A Pharma (4b O37/18) and Hexal (4b O43/18):

Taylor Wessing (Munich): Dr Jan Rektorschek, Dr Nora Wessendorf

Maiwald (Munich): Dr Derk Vos (patent attorney)

The complete Juve article can be downloaded under:
https://www.juve.de/nachrichten/verfahren/2018/10/nachgeprueft-gericht-revidiert-eigenen-beschluss-auf-kosten-von-hogan-lovells-mandantin